BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 11, 2004
View Archived Issues
CuraGen Planning To Pull Down $75M In Convertibles Placement
CuraGen Corp. said it plans to offer $75 million in convertible notes due 2011 in a private placement, with an option for the initial purchaser to buy up to $15 million more. (BioWorld Today)
Read More
Partnering Profile Rising For All Of Asia, Especially China
Read More
Vion Raising $35.2M To Fund Triapine, Cloretazine Progress
Read More
U.S./Canadian, European Biotechnology VC Directories For 2004 Available
Read More
Vitex Proceeds With Financing To Raise $10.9M For Inactine
Read More
Other News To Note
Read More